Neumora Therapeutics, Inc. (NMRA)
0.5715
+0.08
(+15.29%)
USD |
NASDAQ |
Nov 03, 16:00
0.5709
0.00 (0.00%)
After-Hours: 16:59
Neumora Therapeutics Cash and Short Term Investments (Quarterly) : 116.83M for June 30, 2026
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 116.83M |
| March 31, 2026 | 147.07M |
| December 31, 2025 | 182.53M |
| September 30, 2025 | 171.52M |
| June 30, 2025 | 217.59M |
| March 31, 2025 | 250.57M |
| December 31, 2024 | 308.79M |
| September 30, 2024 | 342.52M |
| June 30, 2024 | 371.64M |
| Date | Value |
|---|---|
| March 31, 2024 | 422.72M |
| December 31, 2023 | 453.98M |
| September 30, 2023 | 509.56M |
| June 30, 2023 | 324.20M |
| March 31, 2023 | 345.55M |
| December 31, 2022 | 371.93M |
| September 30, 2022 | |
| June 30, 2022 | |
| March 31, 2022 | 349.67M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| EyePoint, Inc. | 180.47M |
| Context Therapeutics, Inc. | 42.99M |
| LENZ Therapeutics, Inc. | 197.30M |
| BioAge Labs, Inc. | 318.74M |
| ANI Pharmaceuticals, Inc. | 375.87M |